Publications by authors named "Kenneth Webster"

Claim this Profile
E
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trial.
Guolin Xu, Sabina Paglialunga, Xuchen Qian, Ru Ding, Kenneth Webster

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants.
Shichang Miao, Peter Staehr, Ezra Tai, Borje Darpo, Hongqi Xue, Kenneth Webster

Clin Transl Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug-Drug Interaction of Avacopan in 2 Open-Label Studies in Healthy Participants.
Shichang Miao, Pirow Bekker, Danielle Armas, Mary Lor, Yanyan Han, Kenneth Webster

Clin Pharmacol Drug Dev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Scale Insects on Growth Parameters of cv. Chardonnay and cv. Sauvignon Blanc Grapevines Grown in a Greenhouse.
Paul D Cooper, Thy T Truong, Andras Keszei, Teresa Neeman, Kenneth W Webster

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.
David Pierce, Alain Katic, Mary Buckwalter, Kenneth Webster

J Clin Psychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
D Scott McMeekin, Michael W Sill, Kathleen M Darcy, Deborah J Stearns-Kurosawa, Kenneth Webster

Gynecol Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
Joan L Walker, Deborah K Armstrong, Helen Q Huang, Jeffrey Fowler, Kenneth Webster

Gynecol Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma.
Chad M Michener, Gertrude Peterson, Barbara Kulp, Kenneth D Webster, Maurie Markman

J Cancer Res Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged disease-free and treatment-free survival in platinum-resistant ovarian cancer following extended (>1 year) administration of single-agent paclitaxel: A case report and discussion of potential clinical implications.
Maurie Markman, Kenneth Webster, Barbara Kulp, Gertrude Peterson

Cancer Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers.
Maurie Markman, Jon Markman, Kenneth Webster, Kristine Zanotti, Barbara Kulp

J Cancer Res Clin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers.
Maurie Markman, Kenneth Webster, Kristine Zanotti, Barbara Kulp, Gertrude Peterson

Gynecol Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum.
Maurie Markman, Jerome Belinson, Kenneth Webster, Kristine Zanotti, Bei Morrison

Oncology· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
Maurie Markman, Jonathan Markman, Kenneth Webster, Kristine Zanotti, Barbara Kulp

J Clin Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum.
Maurie Markman, Kenneth Webster, Kristine Zanotti, Gertrude Peterson, Barbara Kulp

Gynecol Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials.
Maurie Markman, Kenneth Webster, Kristine Zanotti, Gertrude Peterson, Barbara Kulp

Gynecol Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examples of the marked variability in the relationship between the serum CA-125 antigen level and cancer-related symptoms in ovarian cancer.
Maurie Markman, Kenneth Webster, Kristine Zanotti, Gertrude Peterson, Barbara Kulp

Gynecol Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
Maurie Markman, Kenneth Webster, Kristine Zanotti, Jacqueline Rohl, Jerome Belinson

Gynecol Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteome analysis of adipogenesis.
Gavin I Welsh, Matthew R Griffiths, Kenneth J Webster, Martin J Page, Jeremy M Tavaré

Proteomics· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Jonathan Markman, Kristine Zanotti, Kenneth Webster, Jerome Belinson, Gertrude Peterson

Gynecol Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
Maurie Markman, Fred Hsieh, Kristine Zanotti, Kenneth Webster, Gertrude Peterson

J Cancer Res Clin Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.
Pedro F Escobar, Maurie Markman, Peter Rose, Kristine Zanotti, Kenneth Webster

Gynecol Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
Maurie Markman, Kristine Zanotti, Gertrude Peterson, Barbara Kulp, Kenneth Webster

J Clin Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum.
Maurie Markman, Kristine Zanotti, Kenneth Webster, Gertrude Peterson, Barbara Kulp

Gynecol Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer.
Pedro F Escobar, Maurie Markman, Kristine Zanotti, Kenneth Webster, Jerome Belinson

J Cancer Res Clin Oncol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia.
Maurie Markman, Paul Elson, Barb Kulp, Gertrude Peterson, Kristine Zanotti, Kenneth Webster

Gynecol Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis